<html>
<head>PUBMED IDs for TRIM35</head>
<body bgcolor='#C5F0F2'><h1>TRIM35</h1><a href='https://pubmed.ncbi.nlm.nih.gov/25263439/'>TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.</a> October 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25301557/'>Molecular characterization of a CpTRIM35-like protein and its splice variants from whitespotted bamboo shark (Chiloscyllium plagiosum).</a> July 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25576919/'>Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.</a> January 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28394882/'>miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.</a> June 24  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28394697/'>Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.</a> April 11  2017<br></body></html>
